Trial intelligence / Profile preview

Vasopressin vs Norepinephrine for Shock After Cardiac Surgery

NCT01505231Phase 3Unknown

Sponsor
Universidade de São Paulo
Start
Jan 2012
Primary completion
Feb 2013
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of vasopressin in vasoplegic syndrome (VPS), Shock, sponsored by Universidade de São Paulo. Status: unknown.

02

Drugs

vasopressin
03

Conditions

vasoplegic syndrome (VPS)Shock

Beyond the preview

Go deeper on NCT01505231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01505231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call